Recent Material Events - Cyclacel Pharm (CYCCP)

Filing Date	Description
2008-09-08	Dr. Bacopoulos has not previously held any positions with the Company and has no family relations with any directors or executive officers of the Company. ...
2008-04-02	Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers. ...
2008-03-24	Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers. ...
2008-03-11	The information set forth under this “Item 2.02. Results of Operations and Financial Condition,” including the exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, ...
2007-11-27	Attached as Exhibit 99.1 is a copy of a press release issued by Cyclacel Pharmaceuticals, Inc., a Delaware corporation (the “Company”), dated November 26, 2007, providing an overview of recent advances in its clinical development stage prog ...
2007-10-09	On October 5, 2007, Achilles Acquisition, LLC (“ Achilles ”), a wholly-owned subsidiary of Cyclacel Pharmaceuticals, Inc. (the “ Company ”), entered into a definitive asset purchase agreement (the “ Agreement ”) with ALI ...
2007-06-19	Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ...
2007-04-05	Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ...
2007-03-15	Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ...
2007-03-14	Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ...